A new generation of medical grade Cf-252 sources was developed in 2002 at the Oak Ridge National Laboratory (ORNL). The combination of small size and large activity of these Cf-252 sources makes them suitable to be used with the conventional high-dose-rate (HDR) remote afterloading systems for interstitial brachytherapy. A recent in-water calibration experiment showed that the measured gamma dose rates near the new source are slightly greater than the neutron dose rates; contradicting the well established neutron-to-gamma dose ratio of approximately 2:1 at locations near a Cf-252 brachytherapy source. Specifically, the MCNP-predicted gamma dose rate is a factor of two higher than the measured gamma dose rate at the distance of 1 cm, and the...
Californium-252 promises to be an effective radium substitute in brachy-therapy. In certain situatio...
A collimated source is being developed for possible application to neutron therapy. The source is pr...
The purpose of this work is to evaluate the dose rate distribution and to determine the boron effect...
A new generation of medical grade Cf-252 sources was developed in 2002 at the Oak Ridge National Lab...
In 1995, the American Association of Physicists in Medicine Task Group 43 (AAPM TG-43) published a p...
IntroductionThe use of Cf-252 isotope in the Lithuanian Cancer Center (LCC) was initiated in late 19...
In the present study, all dosimetry parameters around the 252Cf Isotron source for neutron brachythe...
Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2008.Includes bibliographic...
Examination of neutron dosimetry for 252Cf has been conducted using calculative and experimental mea...
ABSTRACT: Californium-252 radioisotopic neutron source capsules have been used for brachytherapy tr...
This work describes the current status of the US low dose rate (LDR) Cf-252 brachytherapy program. T...
The thirteenth Personnel Dosimetry Intercomparison Study (i.e., PDIS 13) was conducted during April ...
The radioisotope {sup 252}Cf is routinely encapsulated into compact, portable, intense neutron sourc...
The Gershenson Radiation Oncology Center of Wayne State University (WSU), Detroit, Michigan, is usin...
The new edition of ISO 8529 series reduced from 4 to 3 standard neutron reference field. Recent stud...
Californium-252 promises to be an effective radium substitute in brachy-therapy. In certain situatio...
A collimated source is being developed for possible application to neutron therapy. The source is pr...
The purpose of this work is to evaluate the dose rate distribution and to determine the boron effect...
A new generation of medical grade Cf-252 sources was developed in 2002 at the Oak Ridge National Lab...
In 1995, the American Association of Physicists in Medicine Task Group 43 (AAPM TG-43) published a p...
IntroductionThe use of Cf-252 isotope in the Lithuanian Cancer Center (LCC) was initiated in late 19...
In the present study, all dosimetry parameters around the 252Cf Isotron source for neutron brachythe...
Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2008.Includes bibliographic...
Examination of neutron dosimetry for 252Cf has been conducted using calculative and experimental mea...
ABSTRACT: Californium-252 radioisotopic neutron source capsules have been used for brachytherapy tr...
This work describes the current status of the US low dose rate (LDR) Cf-252 brachytherapy program. T...
The thirteenth Personnel Dosimetry Intercomparison Study (i.e., PDIS 13) was conducted during April ...
The radioisotope {sup 252}Cf is routinely encapsulated into compact, portable, intense neutron sourc...
The Gershenson Radiation Oncology Center of Wayne State University (WSU), Detroit, Michigan, is usin...
The new edition of ISO 8529 series reduced from 4 to 3 standard neutron reference field. Recent stud...
Californium-252 promises to be an effective radium substitute in brachy-therapy. In certain situatio...
A collimated source is being developed for possible application to neutron therapy. The source is pr...
The purpose of this work is to evaluate the dose rate distribution and to determine the boron effect...